Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Prevention with Persons with HIV

References

  1. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003;52(RR-12):1-24. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5212a1.htm.
  2. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas—2010. HIV Surveillance Supplemental Report 2012;17(No. 3, part A). http://www.cdc.gov/hiv/topics/surveillance/resources/reports/#supplemental. Published June 2012. Accessed July 5, 2012.
  3. Lasry A, Sansom SL, Hicks KA, Uzunangelov V. Allocating HIV prevention funds in the United States: recommendations from an optimization model. PLoS One 2012;7(6):e37545. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0037545.
  4. Centers for Disease Control and Prevention. High-impact prevention: CDC’s approach to reducing HIV infections in the United States. Atlanta, GA: Centers for Disease Control and Prevention; August 2011. http://www.cdc.gov/hiv/strategy/index.htm.

    The Context of Prevention with Persons with HIV

  5. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003;52(RR-12):[1-24]. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5212a1.htm.
  6. U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau. Guide for HIV/AIDS clinical care. Published January 2011. Section on Supporting Patients in Care. http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/. Accessed May 14, 2012.
  7. Americans with Disabilities Act of 1990, as Amended, 42 U.S.C. 12101 et seq. (2008). http://www.ada.gov/pubs/adastatute08.htm. Accessed February 21, 2012.
  8. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral and Revised recommendations for HIV screening of pregnant women. MMWR 2001;50(RR-19):36. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5019a1.htm. Accessed July 12, 2012.
  9. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55(RR-14):11. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm. Accessed March 30, 2012.
  10. Centers for Disease Control and Prevention. HIPAA Privacy Rule and public health: guidance from CDC and the U.S. Department of Health and Human Services. MMWR 2003;52(S-1):1-12. http://www.cdc.gov/mmwr/preview/mmwrhtml/su5201a1.htm. Accessed February 21, 2012.
  11. Centers for Disease Control and Prevention and Health Resources and Services Administration. Recommendations for case management collaboration and coordination in federally funded HIV/AIDS programs. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008. http://www.cdcnpin.org/scripts/features/CaseManagement.pdf. Accessed February 2, 2012.
  12. Centers for Disease Control and Prevention. Data security and confidentiality guidelines for HIV, viral hepatitis, sexually transmitted disease, and tuberculosis programs: standards to facilitate sharing and use of surveillance data for public health action. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011. http://www.cdc.gov/nchhstp/programintegration/docs/PCSIDataSecurityGuidelines.pdf. Accessed May 4, 2012.
  13. Centers for Disease Control and Prevention. Program collaboration and service integration: enhancing the prevention and control of HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis in the United States. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2009. http://www.cdc.gov/nchhstp/programintegration/docs/207181-C_NCHHSTP_PCSI%20WhitePaper-508c.pdf. Accessed February 9, 2012.
  14. Centers for Disease Control and Prevention. HIV Planning Guidance. July 2012.


  15. Linkage to and Retention in HIV Medical Care

  16. Long EF, Brandeau ML, Owens DK. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann Intern Med 2010;153:778–89.
  17. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55(RR-14):1-17. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm. Accessed June 13, 2012.
  18. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR 2001;50(RR-19):1-58. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5019a1.htm. Accessed June 13, 2012.
  19. Centers for Disease Control and Prevention. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR 2008;57(RR-9):1-63. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5709a1.htm. Accessed June 13, 2012.
  20. U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau. Guide for HIV/AIDS clinical care. Published January 2011. Sections on Supporting Patients in Care, Clinic Management, Patient Education, Antiretroviral Therapy and Adherence. http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/. Accessed March 30, 2012.
  21. U.S. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. March 27, 2012. http://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0/. Accessed March 30, 2012.
  22. U.S. Department of Health and Human Services, Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. July 31, 2012:1-235. http://aidsinfo.nih.gov/guidelines/html/3/perinatal-guidelines/0/. Accessed August 27, 2012.
  23. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003;52(RR-12):1-24. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5212a1.htm. Accessed March 30, 2012.
  24. Bosshart J, Vienna M. Recommendations for case management collaboration and coordination in federally funded HIV/AIDS programs. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Health Resources and Services Administration. August 2008. http://www.cdcnpin.org/scripts/features/CaseManagement.pdf. Accessed December 8, 2011.


  25. Risk Screening and Risk-Reduction Interventions

  26. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006;20(10):1447-50.
  27. Centers for Disease Control and Prevention. Clinical and behavioral characteristics of adults receiving medical care for HIV infection—Medical Monitoring Project, United States, 2007. MMWR 2011;60(SS-11):1-20. http://www.cdc.gov/mmwr/preview/mmwrhtml/ss6011a1.htm?s_cid=ss6011a1_e. Accessed June 13, 2012.
  28. Crepaz N, Marks G, Liau A, et al; for the HIV/AIDS Prevention Research Synthesis Team. Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysis. AIDS 2009;23(13):1617-29.
  29. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003;52(RR-12):1-24. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5212a1.htm. Accessed June 13, 2012.
  30. U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau. Guide for HIV/AIDS clinical care. Published January 2011. Sections on Supporting Patients in Care, Patient Education, Preventing HIV Transmission/Prevention with Positives, Antiretroviral Therapy and Adherence.  http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/. Accessed March 6, 2012.
  31. Centers for Disease Control and Prevention. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR 2008;57(RR-9):1-63. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5709a1.htm?s_cid=rr5709a1_e. Accessed June 13, 2012.
  32. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR 2010;59(RR-12):1-110. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5912a1.htm?s_cid=rr5912a1_e. Accessed June 13, 2012.
  33. U.S. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. March 27, 2012. http://www.aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0/. Accessed March 30, 2012.
  34. Centers for Disease Control and Prevention. Serosorting among gay, bisexual and other men who have sex with men. http://www.cdc.gov/msmhealth/Serosorting.htm. Accessed February 23, 2012.
  35. Centers for Disease Control and Prevention. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR 2005;54(RR-2):1-20. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm. Accessed June 13, 2012.
  36. Centers for Disease Control and Prevention. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR 2011;60(3):65-8. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a1.htm?s_cid=mm6003a1_w. Accessed June 13, 2012.
    1. Centers for Disease Control and Prevention. Interim Guidance for Clinicians Considering the Use of Preexposure Prophylaxis for the Prevention of HIV Infection in Heterosexually Active Adults. MMWR 2012;61(31):586-89. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6131a2.htm. Accessed August 27, 2012.
  37. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55(No. RR-14):1-17. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm?s_cid=rr5514a1_e. Accessed June 13, 2012.


  38. Partner Services

  39. Wilson TE, Hogben M, Malka ES, et al. A randomized controlled trial for reducing risk for sexually transmitted infections through enhanced patient-based partner notification. Am J Public Health 2009;99(Suppl 1):S104-10.
  40. Passin WF, Kim AS, Hutchinson AB, et al. A systematic review of HIV partner counseling and referral services: client and provider attitudes, preferences, practices, and experiences. Sex Transm Dis 2006;33:320-8.
  41. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR 2010;59(RR-12):1-110. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5912a1.htm?s_cid=rr5912a1_e. Accessed June 13, 2012.
  42. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003:52( RR-12):1-24. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5212a1.htm. Accessed June 13, 2012.
  43. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55( RR-14):11. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm.
  44. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral (pp. 1-58) and Revised recommendations for HIV screening of pregnant women (pp. 59-86). MMWR 2001;50( RR-19):14-18. http://www.cdc.gov/mmwr/PDF/rr/rr5019.pdf. Accessed July 2, 2012.
  45. Centers for Disease Control and Prevention. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR 2005; 54(RR-2):1-20. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm. Accessed July 2, 2012.
  46. Centers for Disease Control and Prevention. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR 2011;60(3):65-8. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a1.htm?s_cid=mm6003a1_w. Accessed June 13, 2012.
    1. Centers for Disease Control and Prevention. Interim Guidance for Clinicians Considering the Use of Preexposure Prophylaxis for the Prevention of HIV Infection in Heterosexually Active Adults. MMWR 2012;61(31):586-89. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6131a2.htm. Accessed August 27, 2012.
  47. Centers for Disease Control and Prevention. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR 2008;57(RR-9):1-63. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5709a1.htm. Accessed June 13, 2012.


  48. Initiation of and Adherence to Treatment as Prevention

  49. Attia S, Egger M, Müller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009;23(11):1397-404.
  50. Cohen MS, Chen YQ, McCauley M et al. Prevention of HIV-1 Infection with early antiretroviral therapy. N Engl J Med 2011;365(6):493-505.
  51. U.S. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. March 27, 2012. http://www.aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0/. Accessed March 30, 2012.
  52. U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau. Guide for HIV/AIDS clinical care. Published January 2011. Section on Antiretroviral Therapy. http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/. Accessed October 27, 2011.
  53. Centers for Disease Control and Prevention. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR 2005;54(RR-2):1-20. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm
  54. Centers for Disease Control and Prevention. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR 2011;60(3):65-8. Accessed February 14, 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a1.htm?s_cid=mm6003a1_w.
    1. Centers for Disease Control and Prevention. Interim Guidance for Clinicians Considering the Use of Preexposure Prophylaxis for the Prevention of HIV Infection in Heterosexually Active Adults. MMWR 2012;61(31):586-89. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6131a2.htm. Accessed August 27, 2012.
  55. Centers for Disease Control and Prevention. Vital Signs: HIV prevention through care and treatment—United States. MMWR 2011;60(47):1621. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6047a4.htm Accessed July 2, 2011.
  56. U.S. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. March 27, 2012. http://www.aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0/. Accessed March 30, 2012.
  57. U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau. Guide for HIV/AIDS clinical care. Published January 2011. Section on Adherence. http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/. Accessed July 12, 2012.


  58. Sexually Transmitted Diseases (STD) Services

  59. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR 2010;59(RR-12):1-110. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5912a1.htm?s_cid=rr5912a1_e. Accessed July 12, 2012.
  60. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003;52(RR-12):1-24. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5212a1.htm. Accessed July 12, 2012.
  61. Centers for Disease Control and Prevention. Recommendations for the laboratory detection of Chlamydia trachomatis and Neisseria gonorrhoeae. MMWR (in  press).


  62. Reproductive and Pregnancy Care

  63. Craft SM, Delaney RO, Bautista JT, Serovich JM, McDowell T, Grafsky E. Pregnancy decisions among women with HIV. AIDS Behav 2007;11:927-35.
  64. Mugo NR, Donnell D, Wald A, et al; for the Partners in Prevention HSV/HIV Transmission Study Team. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS 2011;25(15):1887-95.
  65. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003;52(RR-12):1-24. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5212a1.htm. Accessed July 12, 2012.
  66. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau. Guide for HIV/AIDS clinical care. Published January 2011. Sections on Reducing Maternal-Infant HIV Transmission and Care of HIV-Infected Pregnant Women. http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/. Accessed September 19, 2011.
  67. U.S. Department of Health and Human Services, Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States; July 31, 2012:1-235. http://aidsinfo.nih.gov/guidelines/html/3/perinatal-guidelines/0/. Accessed August 27, 2012.
  68. Mugo NR, Donnell D, Wald A, et al; for the Partners in Prevention HSV/HIV Transmission Study Team. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS 2011;25(15):1887-95.
  69. Koniak-Griffin D, Brecht ML. AIDS risk behaviors, knowledge, and attitudes among pregnant adolescents and young mothers. Health Educ Behav 1997;24(5):613-24.
  70. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003;52(RR-12):1–24. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5212a1.htm.Accessed July 2, 2012.
  71. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55(RR-14):1-17. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm. Accessed July 12, 2012.
  72. Centers for Disease Control and Prevention. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR 2008;57(No. RR-9):1-63. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5709a1.htm. Accessed July13, 2012.
  73. U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau. Guide for HIV/AIDS clinical care. Published January 2011. Sections on Reducing Maternal-Infant HIV Transmission and Care of HIV-Infected Pregnant Women. http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/. Accessed September 19, 2011.
  74. U.S. Department of Health and Human Services, Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States; July 31, 2012:1-235. http://aidsinfo.nih.gov/guidelines/html/3/perinatal-guidelines/0/. Accessed August 27, 2012.
  75. U.S. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. March 27, 2012. http://www.aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0/. Accessed March 30, 2012.
  76. Centers for Disease Control and Prevention. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2009;58( RR-04):1-198. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5804a1.htm?s_cid=rr5804a1_e. Appendix: Recommendations to help patients avoid exposure to or infection from opportunistic pathogens. MMWR 2009;58(RR-4):199-207. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5804a2.htm?s_cid=rr5804a2_e. Accessed July 13, 2012.
  77. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR 2010;59(RR-12):1-110. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5912a1.htm?s_cid=rr5912a1_e.Accessed July 13, 2012.
  78. Centers for Disease Control and Prevention. U.S. medical eligibility criteria for contraceptive use, 2010. MMWR 2010;59(RR-4):1–85. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5904a1.htm?s_cid=rr5904a1_w. Accessed July 2, 2012.
  79. Centers for Disease Control and Prevention. Update to CDC's U.S. medical eligibility criteria for contraceptive use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV. MMWR 2012;61(24).449–52. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6124a4.htm. Accessed July 3, 2012.
  80. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55(RR-14):1-17. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm. Accessed July 2, 2012.
  81. Centers for Disease Control and Prevention. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years—United States, 2008. MMWR 2008;57(RR-10):1-8. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5710a1.htm?s_cid=rr5710a1_e. Accessed July 20, 2012.
  82. Centers for Disease Control and Prevention. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR 2005;54(RR-2):1–20. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm. Accessed June 27, 2012
    1. Centers for Disease Control and Prevention. Interim Guidance for Clinicians Considering the Use of Preexposure Prophylaxis for the Prevention of HIV Infection in Heterosexually Active Adults. MMWR 2012;61(31):586-89. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6131a2.htm. Accessed August 27, 2012.


  83. Services for Other Medical and Social Issues That Influence HIV Transmission

  84. Aranda-Naranjo B. Quality of life in the HIV-positive patient: implications and consequences. J Assoc Nurses AIDS Care 2004;15(5 Suppl):20S-27S.
  85. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003;52(RR-12):1-24. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5212a1.htm.
  86. Centers for Disease Control and Prevention. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR 2008;57(RR-09):1-63. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5709a1.htm. Accessed June 27, 2012.
  87. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55(RR-14):1-17. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm. Accessed June 20, 2012.
  88. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral (pp. 1-58) and Revised recommendations for HIV screening of pregnant women (pp. 59-86). MMWR 2001;50(RR-19):1-86. http://www.cdc.gov/mmwr/PDF/rr/rr5019.pdf. Accessed June 20, 2012.
  89. Swendeman D, Ingram BL, Rotheram-Borus MJ. Common elements in self-management of HIV and other chronic illnesses: an integrative framework. AIDS Care 2009;21(10):1321-34.
  90. Bosshart J, Vienna M. Recommendations for case management collaboration and coordination in federally funded HIV/AIDS programs. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Health Resources and Services Administration. August 2008. http://www.cdcnpin.org/scripts/features/CaseManagement.pdf. Accessed December 8, 2011.
  91. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR 2010;59(RR-12):1-110. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5912a1.htm?s_cid=rr5912a1_e.Accessed June 13, 2012.
  92. Centers for Disease Control and revention, Division of HIV/AIDS Prevention. HIV planning guidance. July 19, 2012. http://www.cdc.gov/hiv/topics/funding/PS12-1201/pdf/HIV_Planning_Guidance.pdf. Accessed July 24, 2012.


  93. Quality Improvement and Program Monitoring and Evaluation

  94. U.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau. Guide for HIV/AIDS clinical care. Published January 2011. Section 1: The HIV Clinic: Providing Quality Care, http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/. Accessed February 28, 2012.
  95. Centers for Disease Control and Prevention. CDC framework for program evaluation in public health. MMWR 1999;48(RR-11):1-41. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4811a1.htm Accessed July 2, 2012.
  96. Health Resources and Services Administration, HIV/AIDS Bureau. Quality management technical assistance manual. http://careacttarget.org/library/topics/HAB_Quality_Manual_English.pdf. Accessed February 28, 2012.
  97. Health Resources and Services Administration. HAB HIV performance measures. http://hab.hrsa.gov/deliverhivaidscare/habperformmeasures.html. Accessed February 6, 2012.
  98. Centers for Disease Control and Prevention Funding Opportunity Announcement. PS12-1201: Comprehensive HIV prevention programs for health departments. http://www.cdc.gov/hiv/topics/funding/PS12-1201/index.htm.Accessed July 12, 2012.
  99. Centers for Disease Control and Prevention Funding Opportunity Announcement. PS10-1003: HIV prevention projects for community-based organizations. http://www.cdc.gov/hiv/topics/funding/PS10-1003/index.htm.
  100. Centers for Disease Control and Prevention Funding Opportunity Announcement. PS11-1113: HIV prevention projects for young men of color who have sex with men and young transgender persons of color.  http://www.cdc.gov/hiv/topics/funding/PS11-1113/index.htm. Accessed July 12, 2012.
  101. Centers for Disease Control and Prevention. Funding Opportunity Announcement PS11-1117: Enhanced Comprehensive HIV Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS: Phase II. http://www.grants.gov/search/search.do;jsessionid=8Ng3QGkJfdQLVmHQpP1vn5p6KysMjdyl1nwgWcThGpqKX2p8lLPk!-522510686?oppId=82433&mode=VIEW. Accessed July 12, 2012

Top of Page

 


 

Find an HIV testing site near you.

For additional HIV services, select the "More" tab.

Search location, such as: "Atlanta, GA", or "30033".

For more information on this widget, please visit www.aids.gov

Please contact hivwebmaster@cdc.gov with any comments, suggestions, or concerns.

Services








Syndicate This Content Podcast button Tell us what you think button CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO